Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $76.0K | $893K |
| Revenue growth | — | — | — | — | — | 1075.0% |
| Operating income | -$27.0M | -$55.1M | -$153M | -$152M | -$184M | -$165M |
| Operating margin | — | — | — | — | -241678.9% | -18477.8% |
| Net income | -$26.7M | -$55.1M | -$148M | -$35.5M | -$61.2M | -$69.0M |
| Net margin | — | — | — | — | -80507.9% | -7725.2% |
| EPS (diluted) | — | — | -$0.23 | — | — | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$25.2M | -$50.3M | -$77.1M | -$90.1M | -$126M | -$120M |
| Capital expenditures | $5.46M | $5.19M | $1.85M | $34.2M | $29.5M | $15.2M |
| Free cash flow | -$30.6M | -$55.5M | -$78.9M | -$124M | -$156M | -$135M |
| Share buybacks | — | $0.00 | $0.00 | $9.50M | $0.00 | $0.00 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.58M | $20.6M | $490M | $60.6M | $99.1M | $109M |
| Total assets | — | $40.3M | $518M | $421M | $441M | $336M |
| Total liabilities | — | $13.4M | $13.1M | $29.2M | $39.4M | $34.8M |
| Shareholders' equity | $9.86M | $26.9M | -$1.10B | -$1.10B | -$995M | -$1.01B |
| Retained earnings | — | -$162M | -$1.10B | -$1.14B | -$1.20B | -$1.27B |
| Shares (wtd avg diluted) | — | — | 61.5M | — | — | — |
Every figure is extracted from PROKIDNEY CORP.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.